AnnJi Pharmaceutical Co., Ltd. (AnnJi) is a clinical-stage new drug development company focused on the innovation of novel small molecules (NCEs). Our current pipeline targets therapeutic areas including neurology, dermatology, and immune-inflammatory diseases. We are dedicated to developing first-in-class, innovative therapies that address high unmet medical needs, including orphan drugs.